Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Phase 1, Randomized, Double-blind, Placebo-controlled Study of Multiple Doses of SAGE-718 Using Ketamine Challenge to Evaluate the Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Subjects

To see complete record on, please visit this link

Id: NCT03844906

Organisation Name: Sage Therapeutics

Overal Status: Completed

Start Date: December 27, 2018

Last Update: February 4, 2022

Lead Sponsor: Sage Therapeutics

Brief Summary: This study is a Phase 1, randomized, double-blind, placebo-controlled study of multiple doses of SAGE-718 using ketamine challenge to evaluate the electrophysiology, safety, tolerability, and pharmacokinetics in healthy subjects.

  • Healthy Volunteer

Total execution time in seconds: 0.16335797309875